
    
      The study will consist of 254 adult patients, hospitalized for a major depressive episode
      with suicidal ideation and/or behaviour who will be randomized to two groups of each 127
      participants. All study participants will receive treatment as usual in the hospital,
      including (psycho)pharmacological treatment and, if needed, psychotherapy plus a 5-week
      course of lithium or placebo. Rating scales will be used daily resp. weekly to measure
      suicidal ideation and/or behaviour, depression, anxiety, mixed/manic features and
      impulsiveness. Experienced clinicians will rate suicidal ideation and/or behaviour as well as
      depression twice a week and anxiety, mixed/manic features and impulsiveness once a week.
    
  